Boehringer Ingelheim
  • About Pradaxa
  • About Cardiovascular
  • Resources
  • Contact
za
Login

YOUR FORESIGHT. HIS FUTURE.
The first NOAC with
a reversal agent

YOUR FORESIGHT.
HIS FUTURE.

Dabigatran etexilate (Pradaxa®) is proven to be safe and effective to lower the risk of stroke and gives you the assurance of reversibility with Idarucizumab (Praxbind®) in emergency situations.
 
 

safety

NOAC safety in clinical practice: Evidence from the real world

06:52

NOAC safety in clinical practice: Evidence from the real world
NOACS What The Past 5 Years Taught Us

03:16

NOACS What The Past 5 Years Taught Us
Dr. Todd C.Villines: Pradaxa vs other NOACs

03:36

Dr. Todd C.Villines: Pradaxa vs other NOACs
Production date: May 2019
  • Therapeutic Area
  • Metabolic
  • Cardiovascular
  • Respiratory
  • Resources
  • Videos
  • Clinical Studies
  • BI Learning
  • Site map
  • Privacy
  • Terms of use
  • Contact
  • Change country

© 2010-2021
Boehringer Ingelheim International GmbH.
All rights reserved.